| Literature DB >> 28490262 |
Mickael Arnaud1,2, Bernard Bégaud1,2,3, Nicolas Thurin1,2,4, Nicholas Moore1,2,3,4, Antoine Pariente1,2,3,4, Francesco Salvo1,2,3.
Abstract
INTRODUCTION: With increasing availability, the use of healthcare databases as complementary data source for drug safety signal detection has been explored to circumvent the limitations inherent in spontaneous reporting. Areas covered: To review the methods proposed for safety signal detection in healthcare databases and their performance. Expert opinion: Fifteen different data mining methods were identified. They are based on disproportionality analysis, traditional pharmacoepidemiological designs (e.g. self-controlled designs), sequence symmetry analysis (SSA), sequential statistical testing, temporal association rules, supervised machine learning (SML), and the tree-based scan statistic. When considering the performance of these methods, the self-controlled designs, the SSA, and the SML seemed the most interesting approaches. In the perspective of routine signal detection from healthcare databases, pragmatic aspects such as the need for stakeholders to understand the method in order to be confident in the results must be considered. From this point of view, the SSA could appear as the most suitable method for signal detection in healthcare databases owing to its simple principle and its ability to provide a risk estimate. However, further developments, such as automated prioritization, are needed to help stakeholders handle the multiplicity of signals.Keywords: Drug safety; data mining; pharmacoepidemiology; pharmacovigilance; signal detection
Mesh:
Year: 2017 PMID: 28490262 DOI: 10.1080/14740338.2017.1325463
Source DB: PubMed Journal: Expert Opin Drug Saf ISSN: 1474-0338 Impact factor: 4.250